Biotech

All Articles

Analysts dig into Avidity's DMD succeed, uncovering subtleties in records

.Avidity Biosciences impressed entrepreneurs along with period 1/2 records in Duchenne muscle dystro...

Actinogen's cortisol blocker stops working stage 2 clinical depression research

.Actinogen Medical's cortisol blocker has overlooked the major endpoint of a stage 2 study in depres...

Bivictrix decides going personal only technique to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually been at the facility of numerous a billion-dollar bio...

TPG bests up funds to $580M for financial investments throughout life sciences

.Asset manager TPG, which has sustained biotechs such as Sionna Therapies and also Santa Clam Ana Bi...

Merck ceases phase 3 TIGIT trial in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT plan has actually endured one more problem. Months after shuttering a stage ...

After a difficult year, Exscientia folds in to Recursion

.After a year specified through pipe cuts, the departure of its own CEO as well as layoffs, Exscient...

Cullinan, after $25M bargain, restore bispecific to Port

.Cullinan Therapy was excited enough along with Harbour BioMed's bispecific immune activator that it...

A nearer take a look at Intense Biotech's Intense 15

.In this particular full week's episode of "The Best Line," our company're diving into Fierce Biotec...

Lilly encounters period 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's gathering commemorating the approval of Alzheimer's i...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant management hirings, shootings...